Insider · CIK 0001229245

GOOD JENNIFER L

Reports to the SEC for 4 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001229245

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-24	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+3,691 sh	—	—	3,691
2026-06-24	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+2,324 sh	—	—	2,324
2026-06-23	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,712 sh	—	—	11,712
2026-06-23	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,712 sh	—	—	0
2026-02-19	TRVITrevi Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+675K sh	—	—	675,000
2025-06-24	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+7,037 sh	—	—	7,037
2025-06-24	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+4,712 sh	—	—	4,712
2025-06-18	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	—	—	7,000
2025-06-18	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	—	—	0
2025-05-31	TRVITrevi Therapeutics, Inc. · Performance Stock Option (right to buy)A Award	Director, President & CEO	AAward	+102K sh	—	—	156,400
2025-03-21	TRVITrevi Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+5,263 sh	$1.43	+$7,526.09	218,576
2025-03-21	TRVITrevi Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−5,263 sh	$6.58	−$34.6K	213,313
2025-03-21	TRVITrevi Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−5,263 sh	—	—	0
2025-03-10	TRVITrevi Therapeutics, Inc. · Performance Stock Option (right to buy)A Award	Director, President & CEO	AAward	+54.4K sh	—	—	54,400
2025-02-18	TRVITrevi Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+811K sh	—	—	811,000
2024-09-17	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$22.93	+$344K	18,000
2024-09-17	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+9,250 sh	$21.37	+$198K	27,250
2024-09-17	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+7,501 sh	$18.99	+$142K	34,751
2024-09-17	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director	SSale	−31.8K sh	$52.40	−$1.66M	3,000
2024-09-17	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2024-09-17	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,250 sh	—	—	0
2024-09-17	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,501 sh	—	—	0
2024-09-09	TRVITrevi Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+1,840 sh	$1.43	+$2,631.2	215,153
2024-09-09	TRVITrevi Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−1,840 sh	$3.04	−$5,586.608	213,313
2024-09-09	TRVITrevi Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−1,840 sh	—	—	0
2024-09-09	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+12.9K sh	$22.93	+$296K	15,900
2024-09-09	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,305 sh	$21.37	+$92K	20,205
2024-09-09	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,736 sh	$18.99	+$33K	21,941
2024-09-09	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+18.3K sh	$4.15	+$75.9K	40,241
2024-09-09	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director	SSale	−37.2K sh	$50.45	−$1.88M	3,000
2024-09-09	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−12.9K sh	—	—	15,000
2024-09-09	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,305 sh	—	—	9,250
2024-09-09	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,736 sh	—	—	7,501
2024-09-09	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−18.3K sh	—	—	0
2024-09-06	TRVITrevi Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+4,219 sh	$1.43	+$6,033.17	217,532
2024-09-06	TRVITrevi Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−4,219 sh	$3.03	−$12.8K	213,313
2024-09-06	TRVITrevi Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−4,219 sh	—	—	1,840
2024-09-05	TRVITrevi Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+40.3K sh	$1.43	+$57.6K	253,590
2024-09-05	TRVITrevi Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−40.3K sh	$3.11	−$125K	213,313
2024-09-05	TRVITrevi Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−40.3K sh	—	—	6,059
2024-09-04	TRVITrevi Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+11K sh	$1.43	+$15.7K	224,294
2024-09-04	TRVITrevi Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−11K sh	$3.02	−$33.2K	213,313
2024-09-04	TRVITrevi Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−11K sh	—	—	46,336
2024-09-03	TRVITrevi Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+3,863 sh	$1.43	+$5,524.09	217,176
2024-09-03	TRVITrevi Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−3,863 sh	$3.02	−$11.7K	213,313
2024-09-03	TRVITrevi Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−3,863 sh	—	—	57,317
2024-08-26	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,100 sh	$22.93	+$48.2K	5,100
2024-08-26	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,945 sh	$21.37	+$106K	10,045
2024-08-26	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+5,763 sh	$18.99	+$109K	15,808
2024-08-26	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,700 sh	$4.15	+$7,055	17,508

Recent filings

Accepted (ET)
Jun 254
GOOD JENNIFER L0001104659-26-077862
SEC(opens sec.gov)
Feb 204
GOOD JENNIFER L0001193125-26-061391
SEC(opens sec.gov)
Jun 264
GOOD JENNIFER L0001104659-25-063076
SEC(opens sec.gov)
Jun 234
GOOD JENNIFER L0001104659-25-061712
SEC(opens sec.gov)
Jun 34
GOOD JENNIFER L0000950170-25-080883
SEC(opens sec.gov)
Mar 254
GOOD JENNIFER L0000950170-25-044436
SEC(opens sec.gov)
Mar 124
GOOD JENNIFER L0000950170-25-037886
SEC(opens sec.gov)
Feb 204
GOOD JENNIFER L0000950170-25-024110
SEC(opens sec.gov)
Sep 194
GOOD JENNIFER L0001104659-24-101365
SEC(opens sec.gov)

Companies

Address

C/O RHYTHM PHARMACEUTICALS, INC. 222 BERKELEY STREET, 12TH FLOOR

BOSTON, MA, 02116